Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
04/2009
04/07/2009US7514564 Substituted amine derivatives and methods of use
04/07/2009US7514558 e.g. 3-(4-{[6-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)-phenyl]ethyl}amino)-hexyl]oxy}butyl)benzenesulfonamide; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist activity; bronchodilator agent; pulmonary disorders: chronic obstructive pulmonary disease; asthma
04/07/2009US7514461 Chroman derivatives
04/07/2009US7514459 Gamma-secretase inhibitors
04/07/2009US7514456 Nicotinamide derivatives useful as p38 inhibitors
04/07/2009US7514445 Heteroaryl amines as glycogen synthase kinase 3β inhibitors (GSK3 inhibitors)
04/07/2009US7514428 Pesticidal 1-aryl-3-amidoxime-pyrazole derivatives
04/07/2009US7514422 To treat obesity, schizophrenia, anxiety, depression, alcoholism; using 3-benoazepine compounds like 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (lorcaserin); serotonin 2c receptor agonists
04/07/2009US7514225 detecting drugs that inhibits the binding of macrophage migration inhibitory factor (MIF) to an antimacrophage migration inhibitor factor monoclonal or polyclonal antibody; drug screening
04/07/2009CA2393757C Cycloamine ccr5 receptor antagonists
04/07/2009CA2361998C Aromatic heterocyclic compounds as anti-inflammatory agents
04/07/2009CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease
04/02/2009WO2009042907A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
04/02/2009WO2009042485A1 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity
04/02/2009WO2009041521A1 Quinolone derivative
04/02/2009US20090088456 2-Pyridinylethylcarboxamide derivatives and their use as Fugicides
04/02/2009US20090088453 such as biphenyl-2-yl-carbamic acid 1- {2-[5-(4-carbamoylpiperidin-l-ylmethyl)thiophen-2-ylcarbamoyl]ethyl}piperidin-4-yl ester for treating pulmonary disorders (asthma, chronic obstructive pulmonary disease); anticholinergic agents; reduced side effects such as dry mouth and constipation
04/02/2009US20090088450 5-ht7 receptor antagonists
04/02/2009US20090088422 4-imidazolin-2-one compounds
04/02/2009US20090087409 Viral Polymerase Inhibitors
04/02/2009US20090087376 Heterocyclic Dye Compounds For In Vivo Imaging And Diagnosis Of Alzheimer's Disease
04/02/2009CA2700841A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
04/02/2009CA2700539A1 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity
04/02/2009CA2700088A1 Quinolone derivative
04/01/2009EP2041158A2 Peptide epoxyketones for proteasome inhibition
04/01/2009EP2041125A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and agents containing said compounds
04/01/2009EP2041124A1 Pyrazolealkanamide substituted thiophenes as ampa potentiators
04/01/2009EP2041123A2 Fused cyclic compounds
04/01/2009EP2041113A1 Novel pyridazine derivatives
04/01/2009EP2041110A1 2 -oxyheteroarylamide derivatives as parp inhibitors
04/01/2009EP2041086A1 Indole compounds
04/01/2009EP2041085A1 Pyrrole derivatives and their methods of use
04/01/2009EP2040698A2 Oxime compounds and the use thereof
04/01/2009EP2040690A1 Inhibitors of cxcr2
04/01/2009EP2040546A2 Tyrosine kinase inhibitors
04/01/2009EP1653961A4 Inhibitors of akt activity
04/01/2009EP1620429B1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
04/01/2009EP1521744B1 Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists
04/01/2009EP1513530A4 Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex
04/01/2009CN101400674A Antibiotic compounds
04/01/2009CN101400668A 2-(cyclic amino)-pyrimidone derivatives as TPK1 inhibitors
04/01/2009CN101400654A 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors
04/01/2009CN101400651A Diaryl piperidines as CB1 modulators
04/01/2009CN100473652C Thienyl substituted hexa-aryl bis-imidazole and method for preparing the same
04/01/2009CN100473647C Pyridazinones and triazinones and medicinal use thereof
03/2009
03/31/2009US7511159 Azetidine ring compounds and drugs comprising the same
03/31/2009US7511145 Bicyclic heteroaryl derivatives
03/31/2009US7511144 Reverse hydroxamic acid derivatives
03/31/2009US7511136 Anticancer agents; antiproliferative agents; Alzheimer's disease; viricides; autoimmune diseases; central nervous system disorders
03/31/2009US7511068 antiinflammatory agents
03/31/2009US7511066 Antithrombotic aromatic ethers
03/31/2009US7511064 Treating conditions alleviated by 5-HT2B antagonists such as migraine, gastrointestinal disorders; restenosis, asthma, obstructive airway disease, bronchial pulmonary dysplasia, prostatic hyperplasia and priapism; hypotensive agents
03/31/2009US7511062 Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors
03/31/2009US7510822 Aroylmethylsulfonium compounds that are activated by heat or actinic radiation to generate acid
03/31/2009US7510219 Threaded connection for oil field applications
03/26/2009WO2009039397A2 Substituted amides, methods of making, use thereof for the treatment of diseases such as cancer
03/26/2009WO2009039135A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors
03/26/2009WO2009039134A1 Anti-infective pyrimidines and uses thereof
03/26/2009WO2009039127A1 Uracil or thymine derivative for treating hepatitis c
03/26/2009WO2009038157A1 2,3-dihydroiminoisoindole derivative
03/26/2009WO2009037277A1 Compounds useful as ligands and particularly as organic chromophores for complexing lanthanides and applications thereof
03/26/2009WO2009037244A2 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists
03/26/2009WO2009037111A2 Method for the production of 1,3-dioxolane-2-ones and carboxylic acid esters by means of transacylation in basic reaction conditions
03/26/2009WO2009036938A1 Substituted nicotinamide compounds and the use thereof in pharmaceutical products
03/26/2009WO2009016253A3 Cyanomethyl substituted n-acyl tryptamines
03/26/2009WO2008139288A3 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
03/26/2009WO2005067580A3 Naphthofluorescein-based metal sensors, and methods of making and using the same
03/26/2009US20090082567 2,4-pyrimidinediamine compounds and their uses
03/26/2009US20090082404 Benzimidazoles
03/26/2009US20090082401 Deuterium-enriched tiagabine
03/26/2009US20090082372 Arylmethylene Substituted N-Acyl-Beta-Amino Alcohols
03/26/2009US20090082330 Certain substituted amides, method of making, and method of use thereof
03/26/2009US20090082308 histone deacetylase inhibitors; antiproliferative; antineoplastic; thioredoxin (TRX)-mediated diseases such as autoimmune, allergy, inflammatory diseases; and neurodegenerative diseases; hydroxamic acid moiety; 6-Carbamoylmethyl-benzo[b]thiophene-2-carboxylic acid (4-amino-1-phenyl-1H-pyrazol-3-yl)amide
03/26/2009US20090081684 sequence-selective nucleic acid detection; polythiophenes containing pendant quaternary ammonium groups that are thermostable and autoclavable; use in DNA or RNA electrochemical or optical detection, or purification; diagnosis of infections or disease
03/26/2009US20090081165 Bicyclic heteroaryl derivatives
03/26/2009US20090079334 Novel Anthracene Derivatives, Process for Preparation Thereof, and Organic Electronic Light Emitting Device Using the Same
03/26/2009CA2700443A1 Certain substituted amides, method of making, and method of use thereof
03/26/2009CA2699989A1 N-phenyl-dioxo-hydro pyrimidines useful as hepatitis c virus (hcv) inhibitor
03/26/2009CA2699986A1 Anti-infective pyrimidines and uses thereof
03/26/2009CA2699981A1 Uracil or thymine derivative for treating hepatitis c
03/26/2009CA2699909A1 Process for preparing 1,3-dioxolan-2-ones as well as carboxylic acid esters by transacylation under basic reaction conditions
03/26/2009CA2699689A1 Substituted nicotinamide compounds and their use in medicaments
03/26/2009CA2698527A1 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists
03/25/2009EP2038276A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them
03/25/2009EP2038272A2 Pyridinonyl pdk1 inhibitors
03/25/2009EP2038261A2 Pyrazine derivatives with extended conjugation and uses thereof
03/25/2009EP2038259A1 Benzimidazole derivatives, method for the production thereof, their use as fxr agonists and pharmaceutical preparations containing the same
03/25/2009EP2038241A1 Electroluminescent polymers and use thereof
03/25/2009EP2037741A1 Compositions and methods relating to novel compounds and targets thereof
03/25/2009EP1592680B9 2-phenylpyran-4-one derivatives as selective cox-2 inhibitors
03/25/2009EP1357113B1 6-(1-fluoroethyl)-5-iodo-4-aminopyrimidine compounds, process for preparation of the same, and pest controllers for agricultural and horticultural use
03/25/2009CN101395136A New pyridin-3-amine derivatives
03/25/2009CN101394742A Anthranilamide derivatives and their use for the control of insects and acari
03/25/2009CN100471854C Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
03/25/2009CN100471853C Phenyl-thiophene type vitamin D receptor modulators
03/25/2009CN100471845C C 10 ester substituted taxadane
03/25/2009CN100471842C Quinolone derivative or its salt
03/25/2009CN100471841C (2-carboxamido) (3-amino) thiophene compounds
03/24/2009US7507840 Nonlinear optically active compounds that include a pi-donor conjugated to a pi-acceptor through a pi-electron conjugated bridge
03/24/2009US7507839 e,g, 1,5-bis(5-acetyl-4,7-dimethoxybenzofuran-6-yloxy)pentane;potassium channel modulator; antiinflammatory agent, autoimmune diseases; immunosuppressant; multiple sclerosis, rejection of foreign organ transplants